A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

Clinical trial NCT04044690 · TERMINATED

Trial details

NCT number: NCT04044690
Sponsor: CSL Behring
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Dermatomyositis

Start date: 2019-10-21
Primary completion: 2024-12-02
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.